1.
Characteristics | Total | Stroma-poor group | Stroma-rich group | P | |||
n | % | n | % | n | % | ||
P.Y:package.year; Adeno CA:adenocarcinoma; SCC:squamous carcinoma; AdCA:adenosquamous carcinoma. P < 0.05 was considered significant. | |||||||
Gender | |||||||
Men | 50 | 68.5 | 35 | 76.1 | 15 | 55.6 | 0.068 |
Women | 23 | 31.5 | 11 | 23.9 | 12 | 44.4 | |
Age | |||||||
< 60 | 34 | 46.6 | 22 | 47.8 | 12 | 44.4 | 0.780 |
≥60 | 39 | 53.4 | 24 | 52.2 | 15 | 55.6 | |
Smoking history | |||||||
< 20 P.Y | 39 | 53.4 | 26 | 56.5 | 13 | 48.1 | 0.489 |
≥20 P.Y | 34 | 46.6 | 20 | 43.5 | 14 | 51.9 | |
Tumor diameter | |||||||
< 4 cm | 26 | 35.6 | 16 | 34.8 | 10 | 37.0 | 0.846 |
≥4 cm | 47 | 64.4 | 30 | 65.2 | 17 | 63.0 | |
Histology | |||||||
Adeno CA | 33 | 45.2 | 24 | 52.2 | 9 | 33.3 | 0.287 |
SCC | 35 | 47.9 | 19 | 41.3 | 16 | 59.3 | |
Adeno-SC CA | 5 | 6.90 | 3 | 6.50 | 2 | 7.40 | |
Lymphatic metastasis | |||||||
NO | 33 | 45.2 | 23 | 50.0 | 10 | 37.0 | 0.283 |
Yes | 40 | 54.8 | 23 | 50.0 | 17 | 63.0 | |
pTNM stage | |||||||
Ⅰ | 22 | 30.1 | 15 | 32.6 | 7 | 25.9 | 0.429 |
Ⅱ | 28 | 38.4 | 19 | 41.3 | 9 | 33.3 | |
Ⅲ | 23 | 31.5 | 12 | 26.1 | 11 | 40.8 | |
Differentiation grade | |||||||
Well | 18 | 24.7 | 10 | 21.7 | 8 | 29.6 | 0.325 |
Moderate | 34 | 46.5 | 20 | 43.5 | 14 | 51.9 | |
Poor | 21 | 28.8 | 16 | 34.8 | 5 | 18.5 |